Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TRICARE keeps retail

Executive Summary

Mail-order will not be mandatory under the Department of Defense's TRICARE program as passed in the Defense Authorization bill (HR 5122), scoring a victory for community pharmacy. The Senate bill contained a provision that would require beneficiaries to use the TRICARE national mail-order program for refills of most long-term maintenance medications, unless waived by the Secretary of Defense based on clinical need, and eliminate cost sharing for most drugs obtained by mail. The House bill would have established lower copays for mail versus retail. While the conference report did not include these provisions, it does state that DOD is expected to "move toward providing a broad range of incentives to increase the use of the TRICARE national mail-order program"...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel